Simulations Plus, Inc. NASDAQ:SLP

Founder-led company

Simulations Plus stock price today

$13.87
-14.79
-51.61%
Financial Health
0
1
2
3
4
5
6
7
8
9

Simulations Plus stock price monthly change

-31.71%
month

Simulations Plus stock price quarterly change

-31.71%
quarter

Simulations Plus stock price yearly change

-36.83%
year

Simulations Plus key metrics

Market Cap
568.30M
Enterprise value
566.34M
P/E
57.98
EV/Sales
8.08
EV/EBITDA
48.01
Price/Sales
8.22
Price/Book
3.15
PEG ratio
-3.42
EPS
0.58
Revenue
68.71M
EBITDA
12.50M
Income
11.70M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
14.16%
Oper. margin
8.76%
Gross margin
61.63%
EBIT margin
8.76%
EBITDA margin
18.2%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Simulations Plus stock price history

Simulations Plus stock forecast

Simulations Plus financial statements

Simulations Plus, Inc. (NASDAQ:SLP): Profit margin
May 2023 16.23M 4.00M 24.69%
Aug 2023 15.62M 534K 3.42%
Feb 2024 18.30M 4.02M 22.01%
May 2024 18.54M 3.13M 16.92%
Simulations Plus, Inc. (NASDAQ:SLP): Analyst Estimates
Aug 2025 23.36M 3.68M 15.76%
Aug 2025 18.97M 6.08M 32.06%
Nov 2025 22.97M 2.45M 10.7%
Mar 2026 28.64M 6.75M 23.58%
  • Analysts Price target

  • Financials & Ratios estimates

0.62%
Yield TTM
Simulations Plus, Inc. (NASDAQ:SLP): Payout ratio
Payout ratio 48.39%
Simulations Plus, Inc. (NASDAQ:SLP): Dividend Yield
2020 0.4%
2021 0.54%
2022 0.4%
2023 0.54%
2024 0.66%
Simulations Plus, Inc. (NASDAQ:SLP): Debt to assets
May 2023 179134000 9.74M 5.44%
Aug 2023 186101000 16.07M 8.64%
Feb 2024 193973000 16.93M 8.73%
May 2024 192691000 11.83M 6.14%
Simulations Plus, Inc. (NASDAQ:SLP): Cash Flow
May 2023 8.54M 7.91M -628K
Aug 2023 3.06M 520K -1.18M
Feb 2024 5.81M -7.51M -1.05M
May 2024 5.68M 69.91M -3.53M

Simulations Plus alternative data

Simulations Plus, Inc. (NASDAQ:SLP): Employee count
Aug 2023 157
Sep 2023 157
Oct 2023 157
Nov 2023 157
Dec 2023 192
Jan 2024 192
Feb 2024 192
Mar 2024 192
Apr 2024 192
May 2024 192
Jun 2024 192
Jul 2024 192

Simulations Plus other data

70.47% -29.53%
of SLP is owned by hedge funds
14.61M -79.66K
shares is hold by hedge funds

Simulations Plus, Inc. (NASDAQ:SLP): Insider trades (number of shares)
Period Buy Sel
Jan 2024 0 21000
Feb 2024 0 20000
Mar 2024 0 20000
Apr 2024 0 20000
May 2024 0 27400
Jun 2024 0 21400
Jul 2024 0 20000
Aug 2024 0 20000
Sep 2024 0 21400
Oct 2024 0 20000
Nov 2024 0 20000
Dec 2024 0 20650
Transaction Date Insider Security Shares Price per share Total value Source
Sale
WOLTOSZ WALTER S director, 10 perc.. Common Stock 20,000 $31.76 $635,200
Sale
LAVANGE LISA director
Common Stock 650 $31.88 $20,722
Sale
WOLTOSZ WALTER S director, 10 perc.. Common Stock 20,000 $27.66 $553,200
Sale
WOLTOSZ WALTER S director, 10 perc.. Common Stock 20,000 $31.26 $625,200
Sale
WEINER DANIEL L director
Common Stock 750 $31.54 $23,655
Option
FIEDLER-KELLY JILL officer: Business Unit President
Common Stock 2,250 $9.71 $21,848
Option
FIEDLER-KELLY JILL officer: Business Unit President
Employee Stock Option (Right to Buy) 2,250 $9.71 $21,848
Sale
WOLTOSZ WALTER S director, 10 perc.. Common Stock 18,042 $35.13 $633,815
Sale
WOLTOSZ WALTER S director, 10 perc.. Common Stock 1,958 $35.68 $69,861
Sale
LAVANGE LISA director
Common Stock 650 $35.95 $23,368
Insider Compensation
Mr. Shawn M. O'Connor (1960) Chief Executive Officer
$544,230
Mr. William Frederick (1964) Chief Financial Officer & Sec. $371,700
Mr. John Anthony DiBella M.S. (1980) Pres of Lancaster Division
$312,150
Mr. Walter S. Woltosz (1945) Co-Founder & Chairman $91,040
Tuesday, 17 December 2024
businesswire.com
Tuesday, 26 November 2024
zacks.com
Friday, 22 November 2024
zacks.com
Wednesday, 13 November 2024
businesswire.com
Friday, 8 November 2024
zacks.com
Wednesday, 6 November 2024
businesswire.com
Wednesday, 30 October 2024
businesswire.com
Thursday, 24 October 2024
zacks.com
Wednesday, 23 October 2024
seekingalpha.com
zacks.com
Wednesday, 9 October 2024
businesswire.com
Tuesday, 8 October 2024
businesswire.com
Monday, 26 August 2024
zacks.com
Friday, 23 August 2024
businesswire.com
Friday, 12 July 2024
zacks.com
Friday, 5 July 2024
marketbeat.com
Wednesday, 3 July 2024
zacks.com
benzinga.com
Tuesday, 2 July 2024
seekingalpha.com
Tuesday, 25 June 2024
zacks.com
Thursday, 20 June 2024
businesswire.com
Tuesday, 18 June 2024
businesswire.com
Friday, 14 June 2024
zacks.com
Thursday, 13 June 2024
zacks.com
Wednesday, 12 June 2024
businesswire.com
businesswire.com
Wednesday, 22 May 2024
businesswire.com
Thursday, 16 May 2024
zacks.com
Wednesday, 15 May 2024
businesswire.com
Friday, 12 April 2024
InvestorPlace
  • What's the price of Simulations Plus stock today?

    One share of Simulations Plus stock can currently be purchased for approximately $13.87.

  • When is Simulations Plus's next earnings date?

    Simulations Plus, Inc. is estimated to report earnings on Tuesday, 21 Oct 2025.

  • Does Simulations Plus pay dividends?

    Yes, Simulations Plus pays dividends and its trailing 12-month yield is 0.63% with 48% payout ratio. The last Simulations Plus stock dividend of $0.06 was paid on 7 Feb 2022.

  • How much money does Simulations Plus make?

    Simulations Plus has a market capitalization of 568.30M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 17.52% to 70.01M US dollars.

  • What is Simulations Plus's stock symbol?

    Simulations Plus, Inc. is traded on the NASDAQ under the ticker symbol "SLP".

  • What is Simulations Plus's primary industry?

    Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.

  • How do i buy shares of Simulations Plus?

    Shares of Simulations Plus can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Simulations Plus's key executives?

    Simulations Plus's management team includes the following people:

    • Mr. Shawn M. O'Connor Chief Executive Officer(age: 65, pay: $544,230)
    • Mr. William Frederick Chief Financial Officer & Sec.(age: 61, pay: $371,700)
    • Mr. John Anthony DiBella M.S. Pres of Lancaster Division(age: 45, pay: $312,150)
    • Mr. Walter S. Woltosz Co-Founder & Chairman(age: 80, pay: $91,040)
  • Is Simulations Plus founder-led company?

    Yes, Simulations Plus is a company led by its founder Mr. Walter S. Woltosz.

  • How many employees does Simulations Plus have?

    As Jul 2024, Simulations Plus employs 192 workers.

  • When Simulations Plus went public?

    Simulations Plus, Inc. is publicly traded company for more then 28 years since IPO on 18 Jun 1997.

  • What is Simulations Plus's official website?

    The official website for Simulations Plus is simulations-plus.com.

  • Where are Simulations Plus's headquarters?

    Simulations Plus is headquartered at 42505 Tenth Street West, Lancaster, CA.

  • How can i contact Simulations Plus?

    Simulations Plus's mailing address is 42505 Tenth Street West, Lancaster, CA and company can be reached via phone at +66 17 237 723.

Simulations Plus company profile:

Simulations Plus, Inc.

simulations-plus.com
Exchange:

NASDAQ

Full time employees:

243

Industry:

Medical - Healthcare Information Services

Sector:

Healthcare

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, a quantitative systems pharmacology software; NAFLDsym; IPFsym; RENAsym; and MITOsym. In addition, the company provides Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as modeling and simulation products comprising MonolixSuite and PKPlus. Further, it provides population modeling and simulation contract research services; training and consulting services designed to accelerate pharmacometrics studies; and clinical-pharmacology-based consulting services in support of regulatory submissions. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.

42505 Tenth Street West
Lancaster, CA 93534-7059

CIK: 0001023459
ISIN: US8292141053
CUSIP: 829214105